ivf injection side effects
The next generation of IVF technology is here
Now featuring Embryo Predict, the first AI tool to assist in embryo assessment for transfer decisions
Trusted by Fertility Leaders
Meet Embryo Predict
The first commercially available AI tool to aid in assessment of day 5–7 blastocysts for IVF transfer decisions in the U.S.*, supported by a multi-center randomized clinical trial.
Our Platform
An ecosystem of products designed to empower every member of the clinic
Embryo Predict
Give your lab consistent and objective AI embryo scoring to aid in every transfer decision
Schedule Predict
Reduce over capacity retrieval days by up to 65%, lowering operating cost and increasing efficiency
Success Predictor
Increase patient conversion by greater than 3% and improve patient satisfaction
Unlock data to personalize decisions for each patient
Alife Assist™ is a configurable platform designed to help each member of the clinic make more informed, data-based decisions. With seamless EMR integration, Alife's AI-powered software instantly converts raw data into actionable insights.
Scientific Publications
Supported by peer-reviewed research
Scientific Abstract
Fertility and Sterility
Evaluation of artificial intelligence for embryo selection during IVF: A prospective, randomized controller trial
Journal Publication
Fertility and Sterility
Study finds that AI model may help optimize ovulation trigger injection timing to improve outcomes for IVF patients
Journal Publication
RBMO
Study shows that mature oocytes, fertilized oocytes, and usable blastocysts increased in patients who received an optimal dose of FSH
Scientific abstract
Fertility and Sterility
Study shows interpretable machine learning model non-inferior to embryologists in selecting best embryo for IVF transfer
Why IVF clinics like yours choose Alife
"We’ve seen first-hand how Alife’s state-of-the-art, direct-to-patient embryo vitrification reporting boosts operational efficiencies and elevates patient experience."
Kate Devine, MD
Medical Director and Chief Research Officer of US Fertility
Clinic
“Not only have we seen an improvement in laboratory record organization, the improvement in efficiencies has made for a more seamless workflow experience.”
Matthew “Tex” VerMilyea, PhD, HCLD/CC
VP of Scientific Advancement at Ovation Fertility
Lab
“Since incorporating Stim Assist into my practice I have been able to use less medication and obtain more mature eggs.”
Brad Miller, MD
Reproductive Endocrinologist, Reproductive Medicine Associates of Michigan
Clinic
“It is easy to use and the customer service response with the team is excellent.”
Jordan Clarke, MS
Embryologist, Ovation Fertility
Lab
Embryo Predict is now available across the U.S. and Europe
Connect with one of our AI experts to learn how you can optimize your clinic with Alife.
*Embryo Predict is indicated to analyze images of Day 5, 6, and 7 blastocyst-stage embryos that have been deemed suitable for transfer by the embryologist. The device provides adjunctive information to aid in the assessment of blastocysts when there are multiple embryos deemed suitable for transfer or freezing based on standard morphological assessment.
Company
Overview
Team
Career
Book a demo
Customer Support
Patents
Products
Platform Overview
Embryo Predict
Schedule Predict
Success Predictor
Resources
Research
Press & News
Customer Stories
For Patients
Alife App
Blog
IVF Calculator
Sign up for our newsletter for the latest advancements in fertility care.
Subscribe
©2026 by Alife Health
Terms Privacy App Privacy Security Cookie Declaration
[website version: 740-00200-REC-01 Rev 2]